New test could change treatment for 1 in 3 patients with meningioma. A gene expression test can accurately predict the best treatment for meningioma patients by measuring the aggressiveness of their tumors and adjusting treatment accordingly.
Scientists discover a role for the nervous system in keeping itch and allergy under control. Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
UCSF-led trial will combine an anti-amyloid with tau therapies to arrest disease progression. A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.
UCSF-led study puts MDMA on path to be the first psychedelic to seek FDA approval. A clinical trial showed that MDMA, the so-called psychedelic drug also known as "ecstasy" or "molly," can be a powerful new tool in treating people with moderate-to-severe PTSD.
Breakthrough brain implant and digital avatar allow stroke survivor to speak with facial expressions for first time in 18 years. A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.
Researchers discover how exercise, young blood and an anti-aging hormone improve learning and memory. A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function
UCSF-patented device finds resuming sports should be delayed for several days after symptoms have resolved. A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
U.S. News & World Report ranks UCSF Health adult care among nation’s top 10 hospitals in 7 specialties, Best in the West for neurology/neurosurgery and rheumatology. UCSF Medical Center has been ranked among the country’s best hospitals in adult care in U.S. News & World Report’s prestigious Best Hospitals survey.
Biomarker offers critical clue to status of neurological diseases, even without symptoms. An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
UCSF-led research reveals brain changes that promote visual creativity. A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.